![]() |
Volumn 80, Issue 9, 2001, Pages 510-515
|
Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan
|
Author keywords
Acute lymphoblastic leukemia; Philadelphia chromosome
|
Indexed keywords
ANTHRACYCLINE;
ANTILEUKEMIC AGENT;
ANTINEOPLASTIC AGENT;
ASPARAGINASE;
BCR ABL PROTEIN;
CD19 ANTIGEN;
CD2 ANTIGEN;
CD20 ANTIGEN;
CD3 ANTIGEN;
CD34 ANTIGEN;
CD4 ANTIGEN;
CD5 ANTIGEN;
CD7 ANTIGEN;
CD8 ANTIGEN;
COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
GENE PRODUCT;
HEMOGLOBIN;
HLA DR ANTIGEN;
LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN;
MERCAPTOPURINE;
METHOTREXATE;
MONOCLONAL ANTIBODY;
PREDNISOLONE;
PROTEIN TYROSINE KINASE;
T LYMPHOCYTE ANTIGEN;
UNINDEXED DRUG;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ADULT;
AGE;
AGED;
ALLOGENIC BONE MARROW TRANSPLANTATION;
ANTIGEN EXPRESSION;
ARTICLE;
B CELL LEUKEMIA;
BLAST CELL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER RECURRENCE;
CANCER SURVIVAL;
CELL LINEAGE;
CENTRAL NERVOUS SYSTEM DISEASE;
CHROMOSOME ANALYSIS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG MEGADOSE;
EXTRAMEDULLARY HEMATOPOIESIS;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL LINE;
LEUKEMIA REMISSION;
MAJOR CLINICAL STUDY;
MALE;
PHILADELPHIA 1 CHROMOSOME;
PRE B LYMPHOCYTE;
PRIORITY JOURNAL;
PROGNOSIS;
RISK FACTOR;
SEX DIFFERENCE;
TAIWAN;
THROMBOCYTE COUNT;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADOLESCENT;
ADULT;
AGED;
FEMALE;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
PHILADELPHIA CHROMOSOME;
PROGNOSIS;
TAIWAN;
|
EID: 0034794596
PISSN: 09395555
EISSN: None
Source Type: Journal
DOI: 10.1007/s002770100338 Document Type: Article |
Times cited : (11)
|
References (29)
|